Company name: Stenocare
Description: Cultivator of medical cannabis in Denmark. The company cultivates medical cannabis in indoor high-tech culture without the use of pesticides from autumn to autumn ensuring that the prescribed medical cannabis product is better administered to patients.
Year founded: 2017
Industry: Materials and Resources | Group: Agriculture | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: In IPO Registration
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company filed to go public on the Nasdaq OMX Nordic Exchange – AktieTorget under the ticker symbol of STENO on September 21, 2018. They intend to sell 2,113,000 shares at a price of DKK 8.8 per share. The expected offering amount is DKK 18.59 million. Previously, A 25% stake in the company was acquired by CannTrust (TSE: TRST) on March 13, 2018. This is a key step in acquirer’s strategy to expand their best in class products on a global platform.
Number of active investors:
Profile last updated: 12-Oct-2018
Last known valuation: 12.23
Last known valuation date: 21-Sep-2018